TYZINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tyzine, and when can generic versions of Tyzine launch?
Tyzine is a drug marketed by Fougera Pharms and is included in one NDA.
The generic ingredient in TYZINE is tetrahydrozoline hydrochloride. There are two drug master file entries for this compound. Additional details are available on the tetrahydrozoline hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TYZINE?
- What are the global sales for TYZINE?
- What is Average Wholesale Price for TYZINE?
Summary for TYZINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 105 |
Patent Applications: | 1,303 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TYZINE at DailyMed |
![TYZINE drug patent expirations Drug patent expirations by year for TYZINE](/p/graph/s/t/TYZINE-patent-expirations.png)
US Patents and Regulatory Information for TYZINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fougera Pharms | TYZINE | tetrahydrozoline hydrochloride | SOLUTION;NASAL | 086576-002 | Approved Prior to Jan 1, 1982 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Fougera Pharms | TYZINE | tetrahydrozoline hydrochloride | SOLUTION;NASAL | 086576-001 | Approved Prior to Jan 1, 1982 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Fougera Pharms | TYZINE | tetrahydrozoline hydrochloride | SPRAY;NASAL | 086576-003 | Approved Prior to Jan 1, 1982 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |